Filing Details
CapsoVision, Inc (NASDAQ:CV) filed a Form 8-K with the Securities and Exchange Commission on July 02, 2026, disclosing a material event.
8k filedNASDAQ:CV
CapsoVision, Inc (CV) Reports Material Event to SEC
Filing Details CapsoVision, Inc (NASDAQ:CV) filed a Form 8-K with the Securities and Exchange Commission on July 02, 2026, disclosing a material event. Market Context CapsoVision,…
Market Context
CapsoVision, Inc's stock currently trades at $7.28 with a market capitalization of $674.0M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for CapsoVision, Inc's stock.
All SEC filings for CapsoVision, Inc are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View CV Stock Page
Frequently Asked Questions
Where can I read CV's SEC filings?
Browse all filings on our CV SEC filings page.
What types of SEC filings does CapsoVision, Inc file?
Public companies like CapsoVision, Inc file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.